Roth Capital Downgrades vTv Therapeutics (VTVT) to Neutral
Tweet
Share
E-mailGet Alerts VTVT Hot Sheet
Price: $32.90 +4.51%
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Roth Capital downgraded vTv Therapeutics (NASDAQ: VTVT) from Buy to Neutral with a price target of $1.00 (from $17.00).
For an analyst ratings summary and ratings history on vTv Therapeutics click here. For more ratings news on vTv Therapeutics click here.
Shares of vTv Therapeutics closed at $3.26 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Diamondback Energy (FANG) to Equalweight
- Amer Sports Inc. (AS) PT Lowered to $42 at Truist, but 'Momentum continues to surge in a tough macro'
- Target (TGT) PT Raised to $185 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
